Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (201-210 of 304) with videos related to

Pageof 31
Sort By:
British Journal of Cancer|August 1, 1990
Aromatase inhibition in advanced prostatic cancer: preliminary communicationR J Shearer, J H Davies, M Dowsett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedioneR C Stein, M Dowsett, A Hedley, et al.
British Journal of Cancer|October 1, 1996
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancerJ Geisler, N King, M Dowsett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2011
Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancerH Anderson, M Hills, L Zabaglo, et al.
Cancer Research|September 1, 1986
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II reportP E Goss, T J Powles, M Dowsett, et al.
Gynecologic Oncology|October 1, 1996
Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancerA R Jeyarajah, C J Gallagher, P R Blake, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitorsS E Barrie, B P Haynes, G A Potter, et al.
Cytometry|August 13, 1998
Analysis and sorting of apoptotic cells from fine-needle aspirates of excised human primary breast carcinomasM Dowsett, S Detre, M G Ormerod, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
New endocrine agents for the treatment of breast cancerR C Coombes, M Jarman, M Dowsett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistanceS R Johnston, B Lu, G K Scott, et al.
Pageof 31

Showing results (201-210 of 304) with videos related to

Sort By:
Pageof 31
British Journal of Cancer|August 1, 1990
Aromatase inhibition in advanced prostatic cancer: preliminary communicationR J Shearer, J H Davies, M Dowsett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedioneR C Stein, M Dowsett, A Hedley, et al.
British Journal of Cancer|October 1, 1996
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancerJ Geisler, N King, M Dowsett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2011
Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancerH Anderson, M Hills, L Zabaglo, et al.
Cancer Research|September 1, 1986
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II reportP E Goss, T J Powles, M Dowsett, et al.
Gynecologic Oncology|October 1, 1996
Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancerA R Jeyarajah, C J Gallagher, P R Blake, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitorsS E Barrie, B P Haynes, G A Potter, et al.
Cytometry|August 13, 1998
Analysis and sorting of apoptotic cells from fine-needle aspirates of excised human primary breast carcinomasM Dowsett, S Detre, M G Ormerod, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
New endocrine agents for the treatment of breast cancerR C Coombes, M Jarman, M Dowsett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistanceS R Johnston, B Lu, G K Scott, et al.
Pageof 31